Overview
Market
Board of Directors
Financing
Patents

Susan Searle

Susan Searle joined Imperial Innovations in 1994 and has been instrumental in the growth and transformation of the business. Susan was appointed to the position of Chief Executive Officer in January 2002.

Susan previously worked at Montech (Australia), Signet Group plc, Bank of Nova Scotia and Shell Chemicals Limited in the UK and internationally in a variety of business development and commercial roles. Susan possesses over twenty years' commercial experience. Susan has served on the boards of 14 Spin-out companies including TurboGenset Inc., prior to its listing in 2000. Susan is also a director of deltaDOT Limited.

Back

overview | market | board of directors | financing | patents | prevalence | health consequences | current therapies | investors
obesity & appetite regulation
| oxyntomodulin | PYY3-36 | latest news | archives | contact us  
Thiakis Limited: Registered in England & Wales No. 5148298; Registered office - Eighth Floor, 6 New Street Square, London, EC4A 3AQ.
Copyright © 2006 Thiakis Limited. All rights reserved. Legal policy. Designed by Thinking Fish